financetom
Business
financetom
/
Business
/
BRIEF-Spirent Communications & Keysight Working With U.S. & China Regulators For Deal Clearance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Spirent Communications & Keysight Working With U.S. & China Regulators For Deal Clearance
Mar 31, 2025 11:53 PM

April 1 (Reuters) - Keysight Technologies Inc ( KEYS ):

* KEYSIGHT TECHNOLOGS. SPIRENT COMMS. PLC - FURTHER UPDATE

RE:

ACQUISITION OF SPIRENT

* SPIRENT COMMUNICATIONS PLC ( SPNUF ) - SCHEME EXPECTED TO BECOME

EFFECTIVE

BY Q3 FY2025

* SPIRENT COMMUNICATIONS PLC ( SPNUF ) - KEYSIGHT WORKING WITH U.S.

AND

CHINA REGULATORS FOR CLEARANCE

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Medicare says Part D and Advantage premiums will fall in 2025
US Medicare says Part D and Advantage premiums will fall in 2025
Oct 3, 2024
WASHINGTON (Reuters) - Average premiums and benefits for Medicare's prescription drug program and private Medicare plans are projected to remain stable in 2025 with premiums slightly declining, the Centers for Medicare and Medicaid Services said on Friday. WHY IT'S IMPORTANT The premiums are of interest to consumers enrolled in Medicare Advantage plans run by private insurers who are then paid...
BRIEF-Jacobs Advances Strategic Transformation With Completion Of Previously Announced Spin-Off And Merger
BRIEF-Jacobs Advances Strategic Transformation With Completion Of Previously Announced Spin-Off And Merger
Oct 3, 2024
Sept 27 (Reuters) - Jacobs Solutions Inc ( J ): * JACOBS ADVANCES STRATEGIC TRANSFORMATION WITH COMPLETION OF PREVIOUSLY ANNOUNCED SPIN-OFF AND MERGER Source text for Eikon: Further company coverage: ...
Poseida Therapeutics Study of Prospective Myeloma Treatment Yields Positive Data
Poseida Therapeutics Study of Prospective Myeloma Treatment Yields Positive Data
Oct 3, 2024
04:56 PM EDT, 09/27/2024 (MT Newswires) -- Poseida Therapeutics ( PSTX ) said late Friday a phase 1 trial of P-BCMA-ALLO1 therapy to treat relapsed or refractory multiple myeloma, a type of cancer, yielded positive data. The company said data showed an overall response rate of 91% and compelling safety results in the 23 heavily pretreated patients in an optimized...
Salesforce Insider Sold Shares Worth $2,533,877, According to a Recent SEC Filing
Salesforce Insider Sold Shares Worth $2,533,877, According to a Recent SEC Filing
Oct 3, 2024
04:53 PM EDT, 09/27/2024 (MT Newswires) -- Maynard G Webb Jr, Director, on September 26, 2024, sold 9,170 shares in Salesforce ( CRM ) for $2,533,877. Following the Form 4 filing with the SEC, Webb has control over a total of 1,550 shares of the company, with 1,363 shares held directly and 187 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1108524/000112760224024543/xslF345X05/form4.xml Price: 276.59,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved